Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Parallel Randomized Double Blind Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Paroxetine Daily Doses of 15 mg and 20 mg in the Treatment of Premature Ejaculation

NCT01024491 is registered in ClinicalTrials.gov with MorePharma Corporation as lead sponsor.

NCT NCT01024491
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01024491 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Parallel Randomized Double Blind Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Paroxetine Daily Doses of 15 mg and 20 mg in the Treatment of Premature Ejaculation
Lead sponsor
MorePharma Corporation
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2008
Completion date
April 30, 2009
Enrollment
174 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

premature ejaculation